News

Filter

Baxter buys exclusive rights to CTI’s cancer drug pacritinib

18-11-2013

USA-based companies Baxter International and Cell Therapeutics have entered into an exclusive worldwide…

Baxter InternationalCell TherapeuticsFinancialGlobalLicensingOncologypacritinibPharmaceutical

Cell Therapeutics to acquire pacritinib, a potential myelofibrosis drug

20-04-2012

US biotech firm Cell Therapeutics (Nasdaq and MTA: CTIC) and Singapore-based S*BIO Pte have entered into…

BiotechnologyCell TherapeuticsImmunologicalsLicensingOncologypacritinibS*BIO

Cell Thera buys rights to Chroma’s cancer drug candidate tosedostat

15-03-2011

Seattle, USA-based Cell Therapeutics (Nasdaq: CTIC) and UK cancer drug discovery and development firm…

Cell TherapeuticsChroma TherapeuticsLicensingOncologyPharmaceuticaltosedostat

Back to top